Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion

dc.contributor.authorSuman, Prabhat
dc.contributor.authorMehta, Vikrant
dc.contributor.authorCraig, Andrew W. B.
dc.contributor.authorChander, Harish
dc.date.accessioned2024-01-21T10:54:04Z
dc.date.accessioned2024-08-14T07:40:50Z
dc.date.available2024-01-21T10:54:04Z
dc.date.available2024-08-14T07:40:50Z
dc.date.issued2022-01-28T00:00:00
dc.description.abstractInvading tumor cells develop membrane protruding structures called invadopodia to invade and metastasize. Previously, we have reported the role of formin-binding protein-17 (FBP17) in extracellular matrix degradation and invadopodia formation in breast cancer cells. Here, we report a novel axis between tumor-suppressor p53 and FBP17. We observed that cell lines with mutant p53 express FBP17 to a higher level. The expression of FBP17 was reduced upon stabilizing wild-type p53. Furthermore, the immunohistochemistry analysis of breast cancer tissue microarrays demonstrated the correlation between the accumulation of p53 and enhanced FBP17 staining in invasive ductal carcinomas. The double knockdown of p53 and FBP17 showed the contribution of FBP17 in the invasion of cancer cells where p53 lost the regulatory control over FBP17. Taken together, these studies indicate that FBP17 may be a marker to understand the invasion propensity of breast cancer. � 2022 The Author(s). Published by Oxford University Press. All rights reserved.en_US
dc.identifier.doi10.1093/carcin/bgac015
dc.identifier.issn1433334
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/4202
dc.identifier.urlhttps://academic.oup.com/carcin/article/43/5/494/6520863
dc.language.isoen_USen_US
dc.publisherOxford University Pressen_US
dc.subjectBreast Neoplasmsen_US
dc.subjectFatty Acid-Binding Proteinsen_US
dc.subjectFemaleen_US
dc.subjectForminsen_US
dc.subjectHumansen_US
dc.subjectTranscription Factorsen_US
dc.subjectTumor Suppressor Protein p53en_US
dc.subjectformin (protein)en_US
dc.subjectformin binding protein 17en_US
dc.subjectglyceraldehyde 3 phosphate dehydrogenaseen_US
dc.subjectprotein p53en_US
dc.subjecttumor suppressor proteinen_US
dc.subjectunclassified drugen_US
dc.subjectfatty acid binding proteinen_US
dc.subjectmethenamineen_US
dc.subjectprotein p53en_US
dc.subjecttranscription factoren_US
dc.subjectapoptosis assayen_US
dc.subjectArticleen_US
dc.subjectbreast canceren_US
dc.subjectcancer cellen_US
dc.subjectcell invasionen_US
dc.subjectcell proliferationen_US
dc.subjectchromatin immunoprecipitationen_US
dc.subjectcontrolled studyen_US
dc.subjectDU4475 cell lineen_US
dc.subjectfemaleen_US
dc.subjecthumanen_US
dc.subjecthuman cellen_US
dc.subjecthuman tissueen_US
dc.subjectimmunohistochemistryen_US
dc.subjectinvasive ductal carcinomaen_US
dc.subjectMCF-7 cell lineen_US
dc.subjectMDA-MB-157 cell lineen_US
dc.subjectNCI-H1299 cell lineen_US
dc.subjectprotein expressionen_US
dc.subjectRNA isolationen_US
dc.subjecttissue microarrayen_US
dc.subjecttranswell assayen_US
dc.subjecttumor invasionen_US
dc.subjectWestern blottingen_US
dc.subjectbreast tumoren_US
dc.subjectgeneticsen_US
dc.subjectmetabolismen_US
dc.subjectpathologyen_US
dc.titleWild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasionen_US
dc.title.journalCarcinogenesisen_US
dc.typeArticleen_US
dc.type.accesstypeOpen Accessen_US

Files